Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

HeartCore Enterprises (HTCR) Research & Development (2021 - 2025)

HeartCore Enterprises' Research & Development history spans 5 years, with the latest figure at $58146.0 for Q4 2025.

  • For Q4 2025, Research & Development rose 662.87% year-over-year to $58146.0; the TTM value through Dec 2025 reached $592517.0, up 118.05%, while the annual FY2025 figure was $592517.0, 229.61% up from the prior year.
  • Research & Development reached $58146.0 in Q4 2025 per HTCR's latest filing, down from $248997.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $729838.0 in Q4 2023 to a low of $7622.0 in Q4 2024.
  • Average Research & Development over 5 years is $151757.8, with a median of $98696.5 recorded in 2022.
  • Peak YoY movement for Research & Development: skyrocketed 1174.54% in 2023, then crashed 98.96% in 2024.
  • A 5-year view of Research & Development shows it stood at $188883.0 in 2021, then crashed by 69.68% to $57263.0 in 2022, then surged by 1174.54% to $729838.0 in 2023, then crashed by 98.96% to $7622.0 in 2024, then surged by 662.87% to $58146.0 in 2025.
  • Per Business Quant, the three most recent readings for HTCR's Research & Development are $58146.0 (Q4 2025), $248997.0 (Q3 2025), and $161481.0 (Q2 2025).